Prosecution Insights
Last updated: April 19, 2026

Crinetics Pharmaceuticals Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18535503 SOMATOSTATIN SUBTYPE-2 RECEPTOR (SST2R) TARGETED THERAPEUTICS AND USES THEREOF BORALSKY, LUKE ALAN 1624 Non-Final OA Dec 11, 2023
18566887 NON-PEPTIDE TARGETED THERAPEUTICS AND USES THEREOF ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 Non-Final OA Dec 04, 2023

Managing Crinetics Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month